- Home
- MFM vs SMTI Comparison
MFM vs SMTI Comparison
Compare MFM & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFM
- SMTI
- Stock Information
- Founded
- MFM 1986
- SMTI 1982
- Country
- MFM United States
- SMTI United States
- Employees
- MFM N/A
- SMTI N/A
- Industry
- MFM Finance Companies
- SMTI Medical/Dental Instruments
- Sector
- MFM Finance
- SMTI Health Care
- Exchange
- MFM Nasdaq
- SMTI Nasdaq
- Market Cap
- MFM 213.8M
- SMTI 243.3M
- IPO Year
- MFM N/A
- SMTI N/A
- Fundamental
- Price
- MFM $5.34
- SMTI $33.96
- Analyst Decision
- MFM
- SMTI Strong Buy
- Analyst Count
- MFM 0
- SMTI 2
- Target Price
- MFM N/A
- SMTI $50.00
- AVG Volume (30 Days)
- MFM 108.1K
- SMTI 32.3K
- Earning Date
- MFM 01-01-0001
- SMTI 11-11-2025
- Dividend Yield
- MFM 4.08%
- SMTI N/A
- EPS Growth
- MFM N/A
- SMTI N/A
- EPS
- MFM 0.03
- SMTI N/A
- Revenue
- MFM N/A
- SMTI $97,241,894.00
- Revenue This Year
- MFM N/A
- SMTI $24.49
- Revenue Next Year
- MFM N/A
- SMTI $14.43
- P/E Ratio
- MFM $176.67
- SMTI N/A
- Revenue Growth
- MFM N/A
- SMTI 34.29
- 52 Week Low
- MFM $4.37
- SMTI $23.53
- 52 Week High
- MFM $5.48
- SMTI $39.08
- Technical
- Relative Strength Index (RSI)
- MFM 68.62
- SMTI 56.92
- Support Level
- MFM $5.13
- SMTI $33.55
- Resistance Level
- MFM $5.38
- SMTI $35.49
- Average True Range (ATR)
- MFM 0.05
- SMTI 1.30
- MACD
- MFM 0.02
- SMTI -0.09
- Stochastic Oscillator
- MFM 87.10
- SMTI 44.72
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.